Roche's Oncology Drug Strategy Emphasizes Comprehensive Diagnostics

Executives emphasized the role of "comprehensive diagnostics" in its plan to establish a dominant position in immuno-oncology drugs at this years' American Society of Clinical Oncology annual meeting.